Compound: OSI-930

Drug Target: KIT, VEGFR2

Drug Target pathway: RTK signaling

Dataset


Tissue specific analysis

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.